Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
J Clin Immunol ; 31(3): 297-308, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21243521

ABSTRACT

Two hundred and one patients have been diagnosed with primary immunodeficiency diseases (PIDs) in our center from January 2004 to December 2009. The male-to-female ratio was 5.29:1. Spectrums of PIDs were as follows: predominantly antibody deficiency disease was the most common category (94 patients, 48.2%), followed by other well-defined immunodeficiency syndromes (40 patients, 20.5%), combined T and B cell immunodeficiencies (33 patients, 16.9%), congenital defects of phagocyte number and/or function (21 patients, 10.8%), and diseases of immune dysregulation (six patients, 3.1%). Agammaglobulinemia was the most frequent disease type. The median of diagnosis lag was 18.0 months. Pneumonia was the most common manifestation of PID patients. Some manifestations were prone to concentrate in certain diseases. As for therapy, 99 patients (50.8%) received intravenous immunoglobulin replacement therapy; 13 patients received hematopoietic stem cell transplantation and nine of them were still alive. In this study, we sought to describe and analyze the distribution, clinical features, and therapy methods of PIDs among children diagnosed in our country and to compare with reports from other countries and regions.


Subject(s)
Agammaglobulinemia/immunology , Common Variable Immunodeficiency/immunology , Immunoglobulins/pharmacology , Phagocyte Bactericidal Dysfunction/immunology , Severe Combined Immunodeficiency/immunology , Adolescent , Agammaglobulinemia/epidemiology , Agammaglobulinemia/mortality , Agammaglobulinemia/pathology , Agammaglobulinemia/therapy , Anti-Bacterial Agents/pharmacology , Asian People , Child , Child, Preschool , Common Variable Immunodeficiency/epidemiology , Common Variable Immunodeficiency/mortality , Common Variable Immunodeficiency/pathology , Common Variable Immunodeficiency/therapy , Consanguinity , Family , Female , Hematopoietic Stem Cell Transplantation , Humans , Immunoglobulin Isotypes/analysis , Immunoglobulins/immunology , Incidence , Infant , Infant, Newborn , Longitudinal Studies , Male , Phagocyte Bactericidal Dysfunction/epidemiology , Phagocyte Bactericidal Dysfunction/mortality , Phagocyte Bactericidal Dysfunction/pathology , Phagocyte Bactericidal Dysfunction/therapy , Retrospective Studies , Severe Combined Immunodeficiency/epidemiology , Severe Combined Immunodeficiency/mortality , Severe Combined Immunodeficiency/pathology , Severe Combined Immunodeficiency/therapy , Survival Rate
3.
Pediatr Infect Dis J ; 20(9): 889-900, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11734771

ABSTRACT

The field of phagocytic disorders has attained major biologic and clinical significance in the past 40 years. The development of exciting new techniques in molecular biology and the cellular physiology of signal transduction have made it possible to identify the genetic defects involved in many of these disorders. Moreover through immunopharmacologic intervention, bone marrow or peripheral or cord blood stem cell transplantation along with the prospect of gene therapy, we have begun attempts to at least partially correct genetic defects in cell development and activation pathways in the entire spectrum of phagocyte disorders. Carrier detection and prenatal diagnosis employing with chain reaction techniques or direct nucleotide sequencing in fetal blood have made these diseases potentially preventable or treatable in utero or shortly after birth.


Subject(s)
Agranulocytosis/genetics , Granulocytes/physiology , Phagocyte Bactericidal Dysfunction/genetics , Phagocyte Bactericidal Dysfunction/therapy , Phagocytosis/genetics , Agranulocytosis/congenital , Agranulocytosis/physiopathology , Child , Child, Preschool , Chronic Disease , Female , Genetic Therapy/methods , Humans , Infant , Infant, Newborn , Male , Molecular Biology , Phagocyte Bactericidal Dysfunction/diagnosis , Prognosis
4.
Gene Ther ; 7(20): 1725-30, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11083493

ABSTRACT

Macrophages are normal targets for Salmonella during natural infections, and it has been demonstrated that attenuated bacteria can deliver nucleic acid vaccine constructs. Therefore, we assessed if attenuated Salmonella can be used for the in vivo delivery of transgenes to their natural cellular target, in an attempt to correct genetic defects associated with monocytes/macrophages. This system would offer the distinct advantage of achieving a specific targeting of defective cells in a non-invasive form. Using a reporter gene, we demonstrated that attenuated Salmonella could be used as an effective in vitro delivery system to transfer genetic material into nondividing cells like murine macrophages. In vivo, the oral administration of attenuated Salmonella allows targeted delivery of transgenes to macrophages and subsequently expression of transgenes at a systemic level. IFNgamma-deficient mice (GKO) were thus selected as a model for the in vivo validation of the Salmonella-based delivery approach. Attenuated Salmonella, used as the carrier for a eukaryotic expression vector encoding the murine IFNgamma gene, was able to restore the production of this cytokine in GKO macrophages. Their oral administration to IFNgamma-deficient mice also re-established, in these immunocompromised animals, the natural resistance to bacterial infections. These results demonstrate, for the first time, that attenuated Salmonella can be successfully used in vivo as a DNA delivery system for the correction of a genetic defect associated with monocyte/macrophages.


Subject(s)
Genetic Therapy/methods , Genetic Vectors/therapeutic use , Interferon-gamma/deficiency , Phagocyte Bactericidal Dysfunction/therapy , Salmonella typhimurium/genetics , Animals , Female , Gene Transfer Techniques , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Macrophages/immunology , Macrophages/microbiology , Mice , Mice, Inbred BALB C , Opportunistic Infections/prevention & control , Salmonella Infections, Animal/prevention & control , Transgenes
5.
Br J Haematol ; 106(3): 756-61, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10468870

ABSTRACT

We have previously shown that polymorphonuclear leucocytes (PMN) harvested from children with cancer and exposed to chemotherapy exhibit defective bactericidal activities against both Gram-positive and Gram-negative microorganisms as well as accelerated apoptosis. In this study, PMN from children with cancer were evaluated to compare in vitro the corrective effects of the two myeloid colony stimulating factors G-CSF and GM-CSF on these defective pathways. Both G-CSF and GM-CSF were able to increase the defective bactericidal activities against S. aureus and E. coli. However, GM-CSF was consistently superior to G-CSF in correcting PMN microbicidal activity; this correction was incomplete since it did not reach the level observed in normal PMN exposed to GM-CSF. The accelerated apoptosis of PMN was not affected by G-CSF. In contrast, GM-CSF significantly prolonged the survival of the PMN although it did not reach the level of survival observed with normal PMN exposed to GM-CSF. These observations were consistent with other studies indicating that in PMN, microbicidal activities and apoptosis are differentially sensitive to the myeloid growth factors G-CSF and GM-CSF.


Subject(s)
Granulocyte Colony-Stimulating Factor/therapeutic use , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , Leukemia/pathology , Neutrophils/physiology , Phagocyte Bactericidal Dysfunction/therapy , Adolescent , Apoptosis , Child , Child, Preschool , Escherichia coli , Humans , Staphylococcus aureus
7.
Orv Hetil ; 134(32): 1753-6, 1993 Aug 08.
Article in Hungarian | MEDLINE | ID: mdl-8351139

ABSTRACT

Leukocyte adhesion defect (LAD) is an inherited defect of phagocytic function. This disorder is characterised by delayed separation of the umbilical cord, severe recurrent bacterial infections, impaired formation of pus, and high leukocyte counts. The granulocytes have severe defect in their chemotactic mobility and endocytosis. The disease is attributed to the absence of the leukocyte adhesion molecules. (CD11/CD18), which can be verified with monoclonal antibodies. The authors describe the disease-process of the first patient diagnosed in Hungary. Perinatally the omphalitis, periumbilical abscess and periproctal abscess leading to rectovaginal fistula, in the first months the otitis, mastoiditis, and expressed leukocytosis referred to the impaired function of phagocytic cells, which was verified by laboratory tests as well. The decreased inflammation and cicatrization were also striking. This severe form of LAD can be cured only by bone marrow transplantation with preliminary sanitation of the foci of infection. It took about six months. Unfortunately, the patient died of sepsis immediately before transplantation.


Subject(s)
Bacterial Infections/immunology , Immunologic Deficiency Syndromes/genetics , Phagocyte Bactericidal Dysfunction/genetics , Receptors, Leukocyte-Adhesion/immunology , Antibodies, Monoclonal/immunology , Bone Marrow Transplantation , Chemotaxis , Female , Humans , Hungary , Infant, Newborn , Leukocytosis/immunology , Phagocyte Bactericidal Dysfunction/immunology , Phagocyte Bactericidal Dysfunction/therapy , Pulmonary Circulation , Recurrence
8.
Br J Haematol ; 77(2): 150-7, 1991 Feb.
Article in English | MEDLINE | ID: mdl-1672257

ABSTRACT

The role of leucocyte integrins in phagocyte function has been studied by comparing normal neutrophils with those from a patient with partial leucocyte adhesion deficiency (LAD), in whom the levels of CD11b and CD11c were 10% of controls, whereas CD11a levels were normal. Unstimulated LAD neutrophils exhibited defective adhesion to plastic (4.4 +/- 1.5% cf. 14.4 +/- 3.8% in controls), but not to human umbilical vein endothelial cells (HUVECs). The adhesion to HUVECs could be further upregulated by granulocyte-macrophage colony stimulating factor (GM-CSF), but not by 12-O-tetradecanoylphorbol 13-acetate (TPA) which, in normal cells, is a more potent 'pro-adhesive agonist'. The normal neutrophil-endothelial interaction induced by GM-CSF in LAD neutrophils was confirmed in vivo when administration of GM-CSF resulted in rapid phagocyte margination. Neutrophil migration and phagocytosis/killing were defective in LAD neutrophils, and some improvement in phagocytosis/killing was seen following in vivo administration of GM-CSF. These studies illustrate that the degree to which the leucocyte integrins mediate adherence-related phagocyte functions varies not only with the particular function, but also with the conditions of stimulation. High levels of CD11b and CD11c expression appear not to be required for unstimulated or GM-CSF-stimulated neutrophil-endothelial interactions, either in vitro or in vivo. Other neutrophil functions, on the other hand, such as migration and phagocytosis/killing are much more dependent on the leucocyte integrins.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Integrins/immunology , Phagocyte Bactericidal Dysfunction/immunology , Phagocytosis/immunology , Antigens, CD/analysis , Antigens, Differentiation/analysis , CD11 Antigens , Cell Adhesion/immunology , Cell Movement/immunology , Child , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , Humans , Male , Neutrophils/immunology , Phagocyte Bactericidal Dysfunction/therapy
9.
Allergy Proc ; 12(1): 31-6, 1991.
Article in English | MEDLINE | ID: mdl-2040446

ABSTRACT

Neutrophils are the host's first line of defense against many pathogenic bacteria and fungi. Disorders of neutrophil function are often suggested by recurrent cutaneous, periodontal, respiratory, or soft tissue infections. In this review, we summarize the current understanding of neutrophil function, provide an update of recent developments in the field, and outline an approach to diagnosis and management of the major congenital disorders of neutrophils.


Subject(s)
Neutrophils/immunology , Phagocyte Bactericidal Dysfunction , Cell Count , Humans , Neutropenia/immunology , Phagocyte Bactericidal Dysfunction/therapy
11.
Med Hypotheses ; 26(1): 85-8, 1988 May.
Article in English | MEDLINE | ID: mdl-3135468

ABSTRACT

The enhancement of antimicrobial resistance and immunomodulatory action, and the anabolic effect caused by the consumption of live lactobacteria as a dietary adjunct are proposed by the author as sufficient reasons to test lactobacterial preparations in patients with AIDS. The problem of dosage is discussed and a practical solution presented.


Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Immunization/methods , Lactobacillus acidophilus , Opportunistic Infections/therapy , Acetylmuramyl-Alanyl-Isoglutamine/therapeutic use , Acquired Immunodeficiency Syndrome/immunology , Humans , Immunity, Innate , Phagocyte Bactericidal Dysfunction/therapy
12.
Hematol Oncol Clin North Am ; 2(1): 13-31, 1988 Mar.
Article in English | MEDLINE | ID: mdl-3279017

ABSTRACT

CD11/CD18 leukocyte glycoprotein deficiency is a rare, inherited disorder of leukocyte function, manifested by recurrent severe bacterial infections. A deficiency in the expression of a family of leukocyte membrane glycoproteins (the CD11/CD18 glycoproteins) represents the molecular basis for this disease.


Subject(s)
Leukocytes/immunology , Membrane Glycoproteins/deficiency , Phagocyte Bactericidal Dysfunction/immunology , Chemotaxis , Humans , Leukocytes/metabolism , Lymphocytes/immunology , Membrane Glycoproteins/genetics , Phagocyte Bactericidal Dysfunction/diagnosis , Phagocyte Bactericidal Dysfunction/genetics , Phagocyte Bactericidal Dysfunction/therapy , Phagocytosis , Prognosis
13.
Allergol Immunopathol (Madr) ; 16(2): 121-5, 1988.
Article in English | MEDLINE | ID: mdl-3394593

ABSTRACT

A 47 year old female presented with a septic clinical picture including fever, abscesses, late cachexia, and unmanageable by disease. Similar characteristics to chronic granulomatosis disease (CGD) seriously decreased intracellular killing activity and chemiluminescence, granulomas in the histology, and the role of genetic factors were found, suggesting that our case is CGD-like disorder, manifested in an adult. Dialysable leukocyte extract (DLE) therapy, complemented with fresh normal plasma, resulted in a striking clinical improvement and there was an increase in the in vitro PMNL intracellular killing activity, too. Although it is generally accepted that DLE derives from monocytes and lymphocytes, it is possible that DLE is a family of DNA-oligopeptide molecules, including factors derived from PMNLs which are capable of influencing PMNL function, transferring information from normal cells. Our results also suggest that it would be worth trying DLE in patients with classic CGD.


Subject(s)
Neutrophils/pathology , Phagocyte Bactericidal Dysfunction/therapy , Transfer Factor/therapeutic use , Abscess/etiology , Chemotaxis, Leukocyte , Female , Humans , Leukocytes/analysis , Middle Aged , Neutrophils/immunology , Phagocyte Bactericidal Dysfunction/complications , Phagocytosis , Rosette Formation , Transfer Factor/isolation & purification
14.
Tijdschr Kindergeneeskd ; 55(2): 45-53, 1987 Apr.
Article in Dutch | MEDLINE | ID: mdl-3590138

ABSTRACT

When patients suffer from recurrent infections with bacteria or fungi that react poorly with the commonly prescribed antibiotics, phagocyte dysfunctions should be considered. In this article, a survey is given of the mechanism of action of these cells, the dysfunctions that may occur, the resulting clinical symptoms, the laboratory diagnostics and some therapeutical approaches.


Subject(s)
Chemotaxis, Leukocyte , Neutrophils/immunology , Phagocyte Bactericidal Dysfunction/physiopathology , Cell Adhesion , Diagnosis, Differential , Humans , Job Syndrome/immunology , Neutropenia/diagnosis , Neutropenia/physiopathology , Phagocyte Bactericidal Dysfunction/diagnosis , Phagocyte Bactericidal Dysfunction/therapy , Phagocytosis
16.
Clin Immunol Immunopathol ; 40(1): 50-61, 1986 Jul.
Article in English | MEDLINE | ID: mdl-2941193

ABSTRACT

Although inherited forms of phagocyte defects affect a small proportion of the general population, their clinical course can be altered dramatically by a physician's awareness of these diseases and modifications of the approach to and treatment of affected patients. The most common syndromes are chronic granulomatous disease of childhood (CGD), the Chediak-Higashi syndrome (CHS), the hyperimmunoglobulin-E-recurrent infection (Job's) syndrome (HIE), and myeloperoxidase (MPO) deficiency. CGD patients have defects in the oxidative metabolism involved in killing catalase-positive organisms. CHS patients have giant granules defective in fusing with phagosomes and subsequent killing of ingested organisms. HIE patients have abnormal chemotaxis and elevated IgE levels and are susceptible to skin infections with Staphylococcus aureus and recurrent sinopulmonary infections. MPO-deficient patients often go undetected since they rarely have recurrent infections unless they have a concomitant disease such as diabetes mellitus. Patients with a recently described syndrome, C3bi receptor deficiency, have recurrent bacterial infections and persistent leukocytosis, and their neutrophils have abnormal adherence and phagocytosis. The absence of specific granules is a more rare entity but these patients also have recurrent infections thought to be secondary to a chemotactic defect and a minor abnormality of microbial killing exhibited by their neutrophils. This review will focus on the clinical presentation and management of these patients.


Subject(s)
Phagocyte Bactericidal Dysfunction , Chediak-Higashi Syndrome/congenital , Dermatitis/therapy , Fever/therapy , Gingivitis/therapy , Humans , Hypergammaglobulinemia/congenital , Immunoglobulin E , Job Syndrome/congenital , Job Syndrome/immunology , Liver Abscess/therapy , Osteomyelitis/therapy , Phagocyte Bactericidal Dysfunction/congenital , Phagocyte Bactericidal Dysfunction/diagnosis , Phagocyte Bactericidal Dysfunction/immunology , Phagocyte Bactericidal Dysfunction/therapy , Pneumonia/therapy , Receptors, Complement/genetics , Receptors, Complement 3b
17.
Clin Immunol Immunopathol ; 40(1): 62-8, 1986 Jul.
Article in English | MEDLINE | ID: mdl-3521970

ABSTRACT

Mononuclear phagocytes originate from stem cells in the bone marrow which differentiate from monoblasts into promonocytes, then into circulating blood monocytes. Subsequently the monocytes can develop into macrophages and reside in a variety of tissues. Mononuclear phagocytes have cell surface receptors for a variety of substances (e.g., IgG, complement components, fibronectin, and sugars) and are capable of secreting a number of mediators (enzymes, complement components, coagulation components, and monokines). The tissue macrophages adapt to their environment and express unique differentiated functions that are related to various anatomic sites and organs (e.g., Kupffer cells, pulmonary alveolar macrophages, osteoclasts, microglia). Macrophages have the capacity to become "activated" by both specific and nonspecific immunologic stimuli and the "activated" macrophage has enhanced functional capabilities (e.g., tumoricidal, microbicidal, phagocytosis, secretion of mediators). Abnormal monocyte/macrophage function may be acquired or may be due to genetic or developmental disorders. Because of their central role in host defense (in inflammatory responses, in antigen presentation, and in immunoregulatory networks), monocyte/macrophage dysfunction may result in one or more pathophysiologic consequences: defects in monocyte maturation, deficiencies in the clearance of physiologic substrates in lysosomal diseases (e.g., Gaucher's disease, mucopolysaccharidoses, osteopetrosis, metachromatic leukodystrophy), decreased synthesis and secretion of mediators (complement component deficiencies), defects in microbicidal activity (chronic granulomatous disease) and defects which are acquired following infection and during chemotherapy (e.g., acquired immune deficiency syndrome).


Subject(s)
Macrophages/immunology , Monocytes/immunology , Phagocyte Bactericidal Dysfunction , Bone Marrow Transplantation , Cell Cycle , Cell Differentiation , Humans , Lysosomes/enzymology , Macrophages/enzymology , Macrophages/metabolism , Macrophages/pathology , Monocytes/enzymology , Monocytes/metabolism , Monocytes/pathology , Phagocyte Bactericidal Dysfunction/immunology , Phagocyte Bactericidal Dysfunction/pathology , Phagocyte Bactericidal Dysfunction/therapy , Receptors, Fc/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...